Search
Evommune Inc
EVMNAdd to Watchlist
12.960USD
+0.140+1.09%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
466.80MMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
EQT Partners AB
14.68%
EQT Life Sciences
13.69%
RA Capital Management, LP
9.70%
Pivotal Bioventure Partners Investment Advisor LLC
5.35%
Andera Partners S.A.S.
5.27%
Other
51.31%
Shareholders
Shareholders
Proportion
EQT Partners AB
14.68%
EQT Life Sciences
13.69%
RA Capital Management, LP
9.70%
Pivotal Bioventure Partners Investment Advisor LLC
5.35%
Andera Partners S.A.S.
5.27%
Other
51.31%
Shareholder Types
Shareholders
Proportion
Venture Capital
36.77%
Private Equity
19.95%
Investment Advisor
13.95%
Investment Advisor/Hedge Fund
12.52%
Hedge Fund
8.09%
Individual Investor
4.92%
Corporation
3.07%
Research Firm
0.18%
Bank and Trust
0.09%
Other
0.46%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
4
12.40M
0.00%
--
2026Q1
87
33.49M
92.97%
+17.08M
2025Q4
14
14.63M
46.41%
+14.63M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
EQT Partners AB
5.29M
14.68%
+358.68K
+7.28%
Feb 17, 2026
EQT Life Sciences
4.93M
13.69%
+4.93M
--
Nov 07, 2025
RA Capital Management, LP
3.49M
9.7%
+35.87K
+1.04%
Feb 17, 2026
Pivotal Bioventure Partners Investment Advisor LLC
1.93M
5.35%
--
--
Dec 31, 2025
Andera Partners S.A.S.
1.90M
5.27%
--
--
Dec 31, 2025
Nan Fung Life Sciences
1.44M
4%
--
--
Dec 31, 2025
RTW Investments L.P.
1.28M
3.56%
+1.28M
--
Dec 31, 2025
SymBiosis Capital Management, LLC
1.28M
3.56%
--
--
Dec 31, 2025
B Capital Group Management LP
1.10M
3.07%
+1.10M
--
Nov 06, 2025
JP Morgan Asset Management
1.10M
3.06%
+1.10M
--
Dec 31, 2025
View more
Related ETFs
Name
Proportion
No Data